Author details

Full Name

Suraj Peri

Affiliation

ORCID

Career Start Year

2000

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37425776	Unique vulnerability of -mutant melanoma to combined inhibition of CDK9 and immune checkpoints.		2023
37398007	Ribosomal protein control of hematopoietic stem cell transformation through direct, non-canonical regulation of metabolism.	bioRxiv	2023
35082167	Inactivation of p21-Activated Kinase 2 (Pak2) Inhibits the Development of Nf2-Deficient Tumors by Restricting Downstream Hedgehog and Wnt Signaling.	Molecular Cancer Research	2022
35614224	ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis.	Nature	2022
35223446	Tumor-Infiltrating Myeloid Cells Co-Express TREM1 and TREM2 and Elevated TREM-1 Associates With Disease Progression in Renal Cell Carcinoma.	Front Oncol	2022
34927097	Preparation of mouse pancreatic tumor for single-cell RNA sequencing and analysis of the data.	STAR Protocols	2021
34312548	Essential role of a ThPOK autoregulatory loop in the maintenance of mature CD4 T cell identity and function.	Nature Immunology	2021
34081901	ATF3 coordinates serine and nucleotide metabolism to drive cell cycle progression in acute myeloid leukemia.	Molecular Cell	2021
33203643	Somatic Epigenetic Silencing of Inactivates Necroptosis and Contributes to Chemoresistance in Malignant Mesothelioma.	Clinical Cancer Research	2021
33009401	SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate.	Nat Commun	2020
32200799	Influenza Virus Z-RNAs Induce ZBP1-Mediated Necroptosis.	Cell	2020
32071169	Functional proteomics interrogation of the kinome identifies MRCKA as a therapeutic target in high-grade serous ovarian carcinoma.	Sci Signal	2020
32994315	Kinome Profiling of Primary Endometrial Tumors Using Multiplexed Inhibitor Beads and Mass Spectrometry Identifies SRPK1 as Candidate Therapeutic Target.	Molecular and Cellular Proteomics	2020
33087717	Author Correction: SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate.	Nat Commun	2020
32976774	Cholesterol Pathway Inhibition Induces TGF-Î² Signaling to Promote Basal Differentiation in Pancreatic Cancer.	Cancer Cell	2020
32579914	NeuroD1 Dictates Tumor Cell Differentiation in Medulloblastoma.	Cell Rep	2020
31300449	Leukotriene Synthesis Is Critical for Medulloblastoma Progression.	Clin Cancer Res	2019
31581233	RPL22L1 induction in colorectal cancer is associated with poor prognosis and 5-FU resistance.	PLoS One	2019
31827092	BRCA1 intronic Alu elements drive gene rearrangements and PARP inhibitor resistance.	Nature Communications	2019
31555293	Nrf2 Negatively Regulates Type I Interferon Responses and Increases Susceptibility to Herpes Genital Infection in Mice.	Frontiers in Immunology	2019
30295892	Functional Conservation of a Developmental Switch in Mammals since the Jurassic Age.	Molecular Biology and Evolution	2019
30922380	Genomic signature of parity in the breast of premenopausal women.	Breast Cancer Res	2019
31151962	Inactivation of <i>Bap1</i> Cooperates with Losses of <i>Nf2</i> and <i>Cdkn2a</i> to Drive the Development of Pleural Malignant Mesothelioma in Conditional Mouse Models.	Cancer Res	2019
29437795	Statins Synergize with Hedgehog Pathway Inhibitors for Treatment of Medulloblastoma.	Clin Cancer Res	2018
30158636	Nrf2 negatively regulates STING indicating a link between antiviral sensing and metabolic reprogramming.	Nat Commun	2018
29904909	Inactivation of Tp53 and Pten drives rapid development of pleural and peritoneal malignant mesotheliomas.	Journal of Cellular Physiology	2018
29448085	Plk2 Loss Commonly Occurs in Colorectal Carcinomas but not Adenomas: Relationship to mTOR Signaling.	Neoplasia	2018
28122332	The homeoprotein Dlx5 drives murine T-cell lymphomagenesis by directly transactivating Notch and upregulating Akt signaling.	Oncotarget	2017
29176703	NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis.	Nat Commun	2017
28076796	Ribosomal Proteins Rpl22 and Rpl22l1 Control Morphogenesis by Regulating Pre-mRNA Splicing.	Cell Rep	2017
27840425	JUN is a key transcriptional regulator of the unfolded protein response in acute myeloid leukemia.	Leukemia	2017
27682873	Haploinsufficiency in tumor predisposition syndromes: altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutation.	Oncotarget	2017
27453547	HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant.	Gastroenterology	2016
27197267	The BRCA1-Î¿11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin.	Cancer Res	2016
26265441	Phospho-T356RB1 predicts survival in HPV-negative squamous cell carcinoma of the head and neck.	Oncotarget	2015
25344583	Pharmacological profiling of kinase dependency in cell lines across triple-negative breast cancer subtypes.	Molecular Cancer Therapeutics	2015
25521078	Cellular oxidative stress response controls the antiviral and apoptotic programs in dengue virus-infected dendritic cells.	PLoS Pathog	2014
25526308	Noncanonical mode of ERK action controls alternative Î±Î² and Î³Î´ T cell lineage fates.	Immunity	2014
23613854	Anti-CD70 immunocytokines for exploitation of interferon-Î³-induced RIP1-dependent necrosis in renal cell carcinoma.	PLoS ONE	2013
23774303	Whole exome sequence analysis of serous borderline tumors of the ovary.	Gynecologic Oncology	2013
24116146	Meta-analysis identifies NF-ÎºB as a therapeutic target in renal cancer.	PLoS ONE	2013
23633948	Systems analysis of a RIG-I agonist inducing broad spectrum inhibition of virus infectivity.	PLoS Pathog	2013
23657944	NF-ÎºB inhibition by bortezomib permits IFN-Î³-activated RIP1 kinase-dependent necrosis in renal cell carcinoma.	Molecular Cancer Therapeutics	2013
22025034	Pregnancy-induced chromatin remodeling in the breast of postmenopausal women.	Int J Cancer	2012
22689986	CD45-deficient severe combined immunodeficiency caused by uniparental disomy.	Proc Natl Acad Sci U S A	2012
23057841	Defining the genomic signature of the parous breast.	BMC Med Genomics	2012
21622728	Characterization of a genomic signature of pregnancy identified in the breast.	Cancer Prev Res (Phila)	2011
20051372	Altered gene expression in morphologically normal epithelial cells from heterozygous carriers of BRCA1 or BRCA2 mutations.	Cancer Prevention Research	2010
24281036	Overexpression of periostin and lumican in esophageal squamous cell carcinoma.	Cancers	2010
20515954	Early changes in gene expression induced by tobacco smoke: Evidence for the importance of estrogen within lung tissue.	Cancer Prev Res (Phila)	2010